Wright Care Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 08-07-2024
- Paid Up Capital ₹ 2.10 M
as on 08-07-2024
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.21 Cr
as on 08-07-2024
- Satisfied Charges ₹ 14.01 Cr
as on 08-07-2024
- Revenue %
(FY 2021)
- Profit 24.39%
(FY 2021)
- Ebitda 25.69%
(FY 2021)
- Net Worth -0.78%
(FY 2021)
- Total Assets -2.04%
(FY 2021)
About Wright Care Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹30.21 Cr. The company has closed loans amounting to ₹14.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mukta Goyal and Mukut Goyal serve as directors at the Company.
- CIN/LLPIN
U24232RJ2005PTC021611
- Company No.
021611
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Wright Care Remedies?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mukta Goyal | Director | 17-Nov-2005 | Current |
Mukut Goyal | Director | 17-Nov-2005 | Current |
Financial Performance of Wright Care Remedies.
Wright Care Remedies Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 24.39% increase in profit. The company's net worth dipped by a decrease of 0.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Wright Care Remedies?
In 2021, Wright Care Remedies had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Smilax Pharmaceuticals Private LimitedActive 33 years 5 months
Mukta Goyal and Mukut Goyal are mutual person
- Wright Care Drugs Private LimitedActive 20 years 2 months
Mukta Goyal and Mukut Goyal are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 23 May 2023 | ₹7.25 Cr | Open |
State Bank Of India Creation Date: 01 Jun 2020 | ₹22.96 Cr | Open |
Union Bank Of India Creation Date: 03 Dec 2015 | ₹14.01 Cr | Satisfied |
How Many Employees Work at Wright Care Remedies?
Unlock and access historical data on people associated with Wright Care Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wright Care Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wright Care Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.